Results

Total Results: 1,684 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. Slide 1 (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
    September 13, 2006 - consumer behavior, primarily through risk communication Good examples from prostate & breast cancer screening … Potential Lessons for Health Care Social marketing messages for health care (e.g., immunization, screening
  2. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core.PDF
    January 01, 2011 - 4,097 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 810 0.01% 10: Immunizations and screening … 0.04% 27: Cancer of ovary 5,077 0.06% 28: Cancer of other female genital organs 1,314 0.02% 29: Cancerof prostate 20,648 0.26% 30: Cancer of testis 402 0.01% 31: Cancer of other male genital organs 224 … 0.01% 256: Medical examination/evaluation 1,733 0.02% 257: Other aftercare 5,839 0.07% 258: Other screening … Monday, May 20, 2013 60 Frequency Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 663: Screening
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
    June 01, 2011 - Enhancing the use and quality of colorectal cancer screening. … emphasis in the ARRA work and our pilot project on future research on treatments for localized prostatecancer, we are developing explicit lists of research gaps, organized using PICOS, and recommended … Screening program. … supposed to asses all screening programs the Committee requires.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
    June 01, 2011 - Enhancing the use and quality of colorectal cancer screening. … emphasis in the ARRA work and our pilot project on future research on treatments for localized prostatecancer, we are developing explicit lists of research gaps, organized using PICOS, and recommended … Screening program. … supposed to asses all screening programs the Committee requires.
  5. Hlthstat (pdf file)

    meps.ahrq.gov/data_stats/nhc/hlthstat.pdf
    September 30, 1997 - OMB # 0935-0099 DATE: 09/30/97 SP ID: PSF ID: SP NAME: INTERVIEWER NAME: INTERVIEWER ID: DATE OF INTERVIEW: _______/_______/_______ MONTH DAY YEAR TIME INTERVIEW BEGAN: am/pm Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research and National Center for Health…
  6. effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/research-protocol
    December 01, 2019 - Citations determined potentially eligible by either investigator will undergo full text screening. … Differences in screening decisions will be resolved by consultation between investigators and a third … Research Protocol Dec 20, 2024 Primary Hypofractionated Radiation Therapy for Localized ProstateCancer: A Systematic Review Systematic Review Aug 20, 2024 Treatment of Stage I-III
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
    July 01, 2012 - imaging in addition to standard workup after recall for evaluation of a breast lesion detected on screening … to enable women to be appropriately triaged into “biopsy,” “watchful waiting,” or “return to normal screening
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
    July 01, 2012 - imaging in addition to standard workup after recall for evaluation of a breast lesion detected on screening … to enable women to be appropriately triaged into “biopsy,” “watchful waiting,” or “return to normal screening
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Outcome: Adverse events of treatement Factors affecting outcomes Postmenopausal women Men treated for prostatecancer Transplant recipients Nursing home residents, etc. … The reviewers then conducted a second round of screening to ascertain which articles met the inclusion … During the second round of screening, we imposed inclusion criteria based on the particular Key Question … Screening for Osteoporosis: An update for the U.S. Preventive Services Task Force.
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Outcome: Adverse events of treatement Factors affecting outcomes Postmenopausal women Men treated for prostatecancer Transplant recipients Nursing home residents, etc. … The reviewers then conducted a second round of screening to ascertain which articles met the inclusion … During the second round of screening, we imposed inclusion criteria based on the particular Key Question … Screening for Osteoporosis: An update for the U.S. Preventive Services Task Force.
  11. digital.ahrq.gov/sites/default/files/docs/TRANSCRIPT%20OF%20LEVERAGING%20HEALTH%20INFORMATION%20TECHNOLOGY%20FOR%20PATIENT%20EMPOWERMENT_1.pdf
    April 08, 2010 - Currently we have a PHQ2 question embedded into the questionnaire screening for depression. … On our pre-appointment questionnaire we have an added question for screening for at-risk drinking. … and B] (ph) recommendations in the task force, but we did get into some I (ph) recommendations around prostatecancer and other ones to really explore the impact it would have on shared decision-making. … And on average, a person needed 4.6 percent of services; a lot of these were screening services.
  12. www.innovations.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  13. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  14. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  15. www.cahps.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  16. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  17. www.cpsi.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  18. pcmh.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  19. pbrn.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.
  20. healthcare411.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
    September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostatecancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction). … Information provided by diagnostic and screening tests: improving probabilities.